BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23316291)

  • 1. Inhibition of apoptosis signal-regulating kinase 1 reduces myocardial ischemia-reperfusion injury in the mouse.
    Toldo S; Breckenridge DG; Mezzaroma E; Van Tassell BW; Shryock J; Kannan H; Phan D; Budas G; Farkas D; Lesnefsky E; Voelkel N; Abbate A
    J Am Heart Assoc; 2012 Oct; 1(5):e002360. PubMed ID: 23316291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An apoptosis signal-regulating kinase 1 inhibitor reduces cardiomyocyte apoptosis and infarct size in a rat ischemia-reperfusion model.
    Gerczuk PZ; Breckenridge DG; Liles JT; Budas GR; Shryock JC; Belardinelli L; Kloner RA; Dai W
    J Cardiovasc Pharmacol; 2012 Sep; 60(3):276-82. PubMed ID: 22635076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Extracellular Domain (p75ECD) of the Neurotrophin Receptor p75 Attenuates Myocardial Ischemia-Reperfusion Injury by Inhibiting the p-JNK/Caspase-3 Signaling Pathway in Rat Microvascular Pericytes.
    Fang J; Wei Z; Zheng D; Ying T; Hong H; Hu D; Lin Y; Jiang X; Wu L; Lan T; Yang Z; Zhou X; Chen L
    J Am Heart Assoc; 2020 Jul; 9(13):e016047. PubMed ID: 32567476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B7-33, a Functionally Selective Relaxin Receptor 1 Agonist, Attenuates Myocardial Infarction-Related Adverse Cardiac Remodeling in Mice.
    Devarakonda T; Mauro AG; Guzman G; Hovsepian S; Cain C; Das A; Praveen P; Hossain MA; Salloum FN
    J Am Heart Assoc; 2020 Apr; 9(8):e015748. PubMed ID: 32295457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia-reperfusion injury.
    de Hoog VC; Bovens SM; de Jager SC; van Middelaar BJ; van Duijvenvoorde A; Doevendans PA; Pasterkamp G; de Kleijn DP; Timmers L
    Cardiovasc Res; 2015 Dec; 108(3):367-76. PubMed ID: 26449403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo.
    Oerlemans MI; Liu J; Arslan F; den Ouden K; van Middelaar BJ; Doevendans PA; Sluijter JP
    Basic Res Cardiol; 2012 Jul; 107(4):270. PubMed ID: 22553001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influences of remifentanil on myocardial ischemia-reperfusion injury and the expressions of Bax and Bcl-2 in rats.
    Li J; Hu HP; Li Y; Shao W; Zhang JZ; Wang LM
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8951-8960. PubMed ID: 30575939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted focal adhesion kinase activation in cardiomyocytes protects the heart from ischemia/reperfusion injury.
    Cheng Z; DiMichele LA; Hakim ZS; Rojas M; Mack CP; Taylor JM
    Arterioscler Thromb Vasc Biol; 2012 Apr; 32(4):924-33. PubMed ID: 22383703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of PKN mediates survival of cardiac myocytes in the heart during ischemia/reperfusion.
    Takagi H; Hsu CP; Kajimoto K; Shao D; Yang Y; Maejima Y; Zhai P; Yehia G; Yamada C; Zablocki D; Sadoshima J
    Circ Res; 2010 Sep; 107(5):642-9. PubMed ID: 20595653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remote ischemic postconditioning alleviates myocardial ischemia/reperfusion injury by up-regulating ALDH2.
    Zhang ZX; Li H; He JS; Chu HJ; Zhang XT; Yin L
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6475-6484. PubMed ID: 30338817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Preclinical Translational Study of the Cardioprotective Effects of Plasma-Derived Alpha-1 Anti-trypsin in Acute Myocardial Infarction.
    Mauro AG; Mezzaroma E; Marchetti C; Narayan P; Del Buono MG; Capuano M; Prestamburgo A; Catapano S; Salloum FN; Abbate A; Toldo S
    J Cardiovasc Pharmacol; 2017 May; 69(5):273-278. PubMed ID: 28195949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NLRP3 Inflammasome Inhibitor, OLT1177 (Dapansutrile), Reduces Infarct Size and Preserves Contractile Function After Ischemia Reperfusion Injury in the Mouse.
    Toldo S; Mauro AG; Cutter Z; Van Tassell BW; Mezzaroma E; Del Buono MG; Prestamburgo A; Potere N; Abbate A
    J Cardiovasc Pharmacol; 2019 Apr; 73(4):215-222. PubMed ID: 30747785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-1 antitrypsin inhibits caspase-1 and protects from acute myocardial ischemia-reperfusion injury.
    Toldo S; Seropian IM; Mezzaroma E; Van Tassell BW; Salloum FN; Lewis EC; Voelkel N; Dinarello CA; Abbate A
    J Mol Cell Cardiol; 2011 Aug; 51(2):244-51. PubMed ID: 21600901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of A kinase interacting protein 1 attenuates myocardial ischaemia/reperfusion injury but does not influence heart failure development.
    Booij HG; Yu H; De Boer RA; van de Kolk CW; van de Sluis B; Van Deursen JM; Van Gilst WH; Silljé HH; Westenbrink BD
    Cardiovasc Res; 2016 Aug; 111(3):217-26. PubMed ID: 27302402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of the master regulator transcription factor Egr-1 with catalytic oligonucleotides reduces myocardial injury and improves left ventricular systolic function in a preclinical model of myocardial infarction.
    Rayner BS; Figtree GA; Sabaretnam T; Shang P; Mazhar J; Weaver JC; Lay WN; Witting PK; Hunyor SN; Grieve SM; Khachigian LM; Bhindi R
    J Am Heart Assoc; 2013 Jul; 2(4):e000023. PubMed ID: 23902638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase inhibition blunts ischemia/reperfusion injury by inducing cardiomyocyte autophagy.
    Xie M; Kong Y; Tan W; May H; Battiprolu PK; Pedrozo Z; Wang ZV; Morales C; Luo X; Cho G; Jiang N; Jessen ME; Warner JJ; Lavandero S; Gillette TG; Turer AT; Hill JA
    Circulation; 2014 Mar; 129(10):1139-51. PubMed ID: 24396039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant Human Alpha-1 Antitrypsin-Fc Fusion Protein Reduces Mouse Myocardial Inflammatory Injury After Ischemia-Reperfusion Independent of Elastase Inhibition.
    Toldo S; Mauro AG; Marchetti C; Rose SW; Mezzaroma E; Van Tassell BW; Kim S; Dinarello CA; Abbate A
    J Cardiovasc Pharmacol; 2016 Jul; 68(1):27-32. PubMed ID: 26945157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cinaciguat, a novel activator of soluble guanylate cyclase, protects against ischemia/reperfusion injury: role of hydrogen sulfide.
    Salloum FN; Das A; Samidurai A; Hoke NN; Chau VQ; Ockaili RA; Stasch JP; Kukreja RC
    Am J Physiol Heart Circ Physiol; 2012 Mar; 302(6):H1347-54. PubMed ID: 22268103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute humanin therapy attenuates myocardial ischemia and reperfusion injury in mice.
    Muzumdar RH; Huffman DM; Calvert JW; Jha S; Weinberg Y; Cui L; Nemkal A; Atzmon G; Klein L; Gundewar S; Ji SY; Lavu M; Predmore BL; Lefer DJ
    Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):1940-8. PubMed ID: 20651283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrograde infusion of lidocaine or L-arginine before reperfusion reduces myocardial infarct size.
    Lee R; Nitta T; Schmid RA; Schuessler RB; Harris KM; Gay WA
    Ann Thorac Surg; 1998 May; 65(5):1353-9. PubMed ID: 9594866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.